B. Braun Medical Inc. Issues Voluntary Nationwide Recall of Lot H3A744, 1 gram Cefepime for Injection USP and Dextrose Injection USP Due to Visible Particulate Matter

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: B. Braun Medical Inc. Issues Voluntary Nationwide Recall of Lot H3A744, 1 gram Cefepime for Injection USP and Dextrose Injection USP Due to Visible Particulate Matter

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

B. Braun Medical Inc. Issues Voluntary Nationwide Recall of Lot H3A744, 1 gram Cefepime for Injection USP and Dextrose Injection USP Due to Visible Particulate Matter

10/15/2013 04:39 PM EDT

B. Braun Medical Inc. (B.Braun) is voluntarily recalling one lot of 1g Cefepime for Injection USP and Dextrose Injection USP (Lot H3A744, catalog 3193-11) to the consumer level. The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@xxxxxxxxxxxxxxx
• Other inquiries? webmail@xxxxxxxxxx

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420